Literature DB >> 16256139

Effect of ischemic preconditioning on rat liver microcirculation monitored with laser Doppler flowmetry.

Attila Szijártó1, Oszkár Hahn, Gábor Lotz, Zsuzsa Schaff, Emilia Madarász, Péter Károly Kupcsulik.   

Abstract

BACKGROUND: Ischemic preconditioning (IP) may protect the liver from ischemia-reperfusion (I-R) injury during liver resection. This study investigated the effect of IP on hepatic microcirculation (HM) and analyzed the objective parameters of the HM using laser Doppler flowmetry (LDF).
METHODS: We used male Wistar rats (250-280 g) that underwent normothermic, segmental liver ischemia. The animals were divided into eight groups: 30, 45, 60, and 90 min of ischemia with, or without, IP. Five minutes ischemia and 10 min reperfusion, in two cycles, were used to elicit IP. Changes of the hepatic microcirculation were studied by LDF with on-line computer monitoring and processing. Histological alterations, liver enzymes, bilirubin, and TNF-alpha level were all measured simultaneously.
RESULTS: Reperfusion was assessed by post-ischemia flux plateau maximum (PM) and by the area under the reperfusion-curve (RA). Both PM and RA are inversely correlated with the duration of ischemia. The groups with IP had significantly (P < 0.05) higher flow values than groups without preconditioning. IP before liver ischemia resulted in significantly (P < 0.05) lower TNF-alpha levels at the end of the 30-min reperfusion. Lower serum ALT, LDH, and bilirubin levels could only be observed at 45 and 60 min I-R during the first post-operative day. On the seventh post-operative day there were no significant differences between the I-R and IP + IR groups in any of these parameters.
CONCLUSION: The benefit of ischemic preconditioning on hepatic microcirculation was well demonstrated with this method, which has never been described before, in this context. Changes in hepatic microcirculation can be precisely investigated by laser Doppler flowmetry using the standardization and transformation described in this paper.

Entities:  

Mesh:

Year:  2005        PMID: 16256139     DOI: 10.1016/j.jss.2005.09.002

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

Review 1.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Post-conditioning through lower limb ischemia-reperfusion can alleviate lung ischemia-reperfusion injury.

Authors:  Shi-Qiu Song; Hui-Li Gan; Jian-Qun Zhang; Lei Feng; Jian-Chao Sun; Sheng-Xun Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Ischemic preconditioning and intermittent ischemia preserve bile flow in a rat model of ischemia/reperfusion injury.

Authors:  Vincent B Nieuwenhuijs; Menno T de Bruijn; Marc Schiesser; Arthur Morphett; Robert T A Padbury; Greg J Barritt
Journal:  Dig Dis Sci       Date:  2007-07-31       Impact factor: 3.199

4.  Ischemic preconditioning and intermittent ischemia preserve bile flow in a rat model of ischemia reperfusion injury.

Authors:  Vincent B Nieuwenhuijs; Menno T de Bruijn; Marc Schiesser; Arthur Morphett; Robert T A Padbury; Greg J Barritt
Journal:  Dig Dis Sci       Date:  2007-03-14       Impact factor: 3.487

5.  Postconditioning in major vascular surgery: prevention of renal failure.

Authors:  Peter Aranyi; Zsolt Turoczi; David Garbaisz; Gabor Lotz; Janos Geleji; Viktor Hegedus; Zoltan Rakonczay; Zsolt Balla; Laszlo Harsanyi; Attila Szijarto
Journal:  J Transl Med       Date:  2015-01-27       Impact factor: 5.531

6.  Meta-analysis of ischemic preconditioning (IP) on postoperative outcomes after liver resections.

Authors:  Xingjun Guo; Gongpan Liu; Xiaobin Zhang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

7.  Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?

Authors:  Peter Onody; Rita Stangl; Andras Fulop; Oliver Rosero; David Garbaisz; Zsolt Turoczi; Gabor Lotz; Zoltan Rakonczay; Zsolt Balla; Viktor Hegedus; Laszlo Harsanyi; Attila Szijarto
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

8.  Attenuation of skeletal muscle and renal injury to the lower limb following ischemia-reperfusion using mPTP inhibitor NIM-811.

Authors:  David Garbaisz; Zsolt Turoczi; Peter Aranyi; Andras Fulop; Oliver Rosero; Edit Hermesz; Agnes Ferencz; Gabor Lotz; Laszlo Harsanyi; Attila Szijarto
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

9.  Levosimendan Administration in Limb Ischemia: Multicomponent Signaling Serving Kidney Protection.

Authors:  Peter Onody; Peter Aranyi; Zsolt Turoczi; Rita Stangl; Andras Fulop; Emese Dudas; Gabor Lotz; Attila Szijarto
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.